Nebraska Methodist — Omaha, Nebraska

Nebraska Methodist is a clinical research site located in Omaha, Nebraska, United States 68118.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Methodist has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Deep Vein Thrombosis, DVT, TNBC - Triple-Negative Breast Cancer.

Sponsors: Penumbra Inc., Personalis Inc., Helsinn Healthcare SA.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist?

Nebraska Methodist has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist conducted?

Nebraska Methodist has 4 clinical trials on record, with 3 currently active. Their work covers Deep Vein Thrombosis, DVT, TNBC - Triple-Negative Breast Cancer.

Is Nebraska Methodist accredited by Crixeo Health?

Yes — Nebraska Methodist holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Nebraska Methodist?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.